• Learning Objective 1:  To  understand the role of dyslipidemia in the lifetime risk of cardiovascular disease
  • Learning Objective 2:  To understand the evidence base for childhood screening for genetic dyslipidemia
  • Learning Objective 3:  To understand lifestyle and pharmacologic approaches to the treatment of dyslipidemia
Session date: 
04/13/2023 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stephan Daniels, MD, PhD, FAHA